Changes in GABAA receptor properties in amygdala kindled animals: In vivo studies using [11C]flumazenil and positron emission tomography
β Scribed by Lia C. Liefaard; Bart A. Ploeger; Carla F. M. Molthoff; Hugo W. A. M. De Jong; Jouke Dijkstra; Louise Van Der Weerd; Adriaan A. Lammertsma; Meindert Danhof; Rob A. Voskuyl
- Book ID
- 109110927
- Publisher
- Wiley (Blackwell Publishing)
- Year
- 2009
- Tongue
- English
- Weight
- 436 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0013-9580
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The dopamine D-1 receptor antagonist, SCH 23390 ((R)-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3- benzazepin-7-ol), was labelled by alkylation of the desmethyl compound SCH 24518 ((R)-(+)-8-chloro-2,3,4,5-tetrahydro-5-phenyl-1H-3-benzazepin-7- ol) with [11C]methyl iodide. A multivariate o
Dexetimide (Fig. la), a potent muscarinic cholinergic receptor antagonist, and levetimide (Fig. lb), its pharmacologically inactive enantiomer, were labeled with "C for non-invasive in vivo studies of muscarinic cholinergic receptors in the human brain using positron emission tomography. The synthes